Perturbation of the Hematopoietic Profile by Anabolic Androgenic Steroids

Table 1

Characteristic data of study group 1 at the time of inclusion (visit 1) and after 6 months cessation of AAS.

Mean age (range)	26.4 y (18–57)
AAS duration (range)	5.2 y (0.5–17)
Last AAS intake (range)	84 days ago (0–365)
% Tested positive for
Nandrolone	61%
Testosterone	54%
Stanozolol	35%
Total Testosterone concentration
Mean (range) visit 1	19.1 mmol/L (0.7–137)
Mean (range) visit 2	14.2 mmol/L (5.6–49)
% Hypogonadal; <12 mmol/L
Visit 1	63%
Visit 2	43%